NCT03342352 2019-12-20Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)Incyte CorporationPhase 3 Withdrawn
NCT03386838 2019-04-18An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and NeckBristol-Myers SquibbPhase 3 Withdrawn
NCT02013453 2014-12-02A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck CancerUniversity of Michigan Rogel Cancer CenterPhase 2 Withdrawn